首页> 外国专利> Stnfr truncated tumor necrosis-binding protein and polyvalent polynucleotide nucleic acid sequence polynucleotide vector c-cell procardiotic host pharmaceutical composition processes for silvering a disease mediated by tnf e to prepare a pharmaceutical composition using the tumor necrosis factor binding protein and kit

Stnfr truncated tumor necrosis-binding protein and polyvalent polynucleotide nucleic acid sequence polynucleotide vector c-cell procardiotic host pharmaceutical composition processes for silvering a disease mediated by tnf e to prepare a pharmaceutical composition using the tumor necrosis factor binding protein and kit

机译:Stnfr截短的肿瘤坏死结合蛋白和多价多核苷酸核酸序列多核苷酸载体c细胞促心病宿主药物组合物的方法,用于制备由tnf e介导的疾病的银,以使用肿瘤坏死因子结合蛋白和试剂盒制备药物组合物

摘要

Disclosed are novel proteins, referred to as tumor necrosis factor binding proteins, that modulate the activity of tumor necrosis factor. Also disclosed are processes for obtaining the tumor necrosis binding proteins by recombinant genetic engineering techniques.
机译:公开了新型蛋白,称为肿瘤坏死因子结合蛋白,其调节肿瘤坏死因子的活性。还公开了通过重组基因工程技术获得肿瘤坏死结合蛋白的方法。

著录项

  • 公开/公告号BR9710350A

    专利类型

  • 公开/公告日1999-08-17

    原文格式PDF

  • 申请/专利权人 AMGEN INC.;

    申请/专利号BR19979710350

  • 申请日1997-07-09

  • 分类号C12N15/12;C07K14/715;C07K1/107;A61K38/17;A61K47/48;A61K49/00;

  • 国家 BR

  • 入库时间 2022-08-22 02:28:05

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号